Lung AI vs CT Cardiomegaly

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Lung AI

by Exo

CT Cardiomegaly

by Innolitics

AI Verdict

Tool A is a handheld ultrasound platform with integrated AI for real-time cardiac and lung scanning, enabling immediate clinical decisions at the point of care. In contrast, Tool B is a command-line software that automates cardiothoracic ratio measurements from existing CT chest images for cardiomegaly detection. While both leverage AI for cardiac imaging analysis, they utilize different modalities and deployment strategies, making them suitable for distinct clinical workflows.

Choose Lung AI if…

Choose Lung AI if you require immediate, real-time diagnostic insights at the point of care, particularly in emergency medicine or critical care settings. This handheld AI ultrasound is ideal for rapid bedside assessments of cardiac and lung conditions, offering on-device AI processing and guided image capture for efficient decision-making.

View Lung AI →

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if your workflow involves analyzing existing CT chest images to automatically and quantitatively measure the cardiothoracic ratio. This command-line software is best suited for integrating into radiology departments for automated reporting and providing precise, validated data to assist physicians in detecting cardiomegaly from CT scans.

View CT Cardiomegaly →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Lung AI	CT Cardiomegaly
Pricing	Contact for pricing	Contact for pricing
Deployment	On-device (integrated with Exo Iris handheld ultrasound device)	Docker Container (Ubuntu 20.04), command-line software
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Lung AI

Tool A (Lung AI) is designed as an 'easy-to-use medical imaging' handheld device with 'guided image capture' and 'AI-powered POCUS education and training' (Exo U), suggesting a direct and intuitive clinician experience at the point of care. In contrast, Tool B (CT Cardiomegaly) is described as 'command-line software' deployed as a 'Docker Container,' indicating a more technical integration into existing IT infrastructure rather than direct end-user interaction.

Clinical Value

Lung AI

Tool A (Lung AI) offers real-time, AI-powered detection for multiple conditions such as pleural effusion, consolidation/atelectasis, and cardiac indicators, providing immediate diagnostic assistance at the point of care. Studies show it benefits both novice and experienced users, with performance approaching expert level. Tool B (CT Cardiomegaly) automates a specific quantitative measurement (cardiothoracic ratio) from CT images, assisting in cardiomegaly detection with validated data, which is valuable but more focused and not real-time at the point of care.

Pricing & Value

Lung AI

Tool A (Lung AI) offers a transparent starting price for its Iris system at $3,500 in the U.S., providing a clear entry point for potential buyers. Tool B (CT Cardiomegaly) only states 'contact for pricing,' making it difficult to assess its value proposition without direct vendor engagement.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness but through different deployment models. Tool A (Lung AI) is an integrated hardware/software solution that connects with EHR systems and existing IT platforms for image storage, offering a comprehensive ecosystem. Tool B (CT Cardiomegaly), as a Docker container and command-line software, provides a flexible, software-only solution highly adaptable for integration into existing enterprise PACS/RIS workflows without requiring new hardware. Both are HIPAA compliant and offer BAAs.

Innovation

Lung AI

Tool A (Lung AI) represents a significant innovation by integrating AI directly into a high-performance, handheld ultrasound device for real-time, on-device processing and diagnostic assistance, even operating without internet. This comprehensive ecosystem, coupled with educational tools (Exo U), offers a potentially disruptive approach to medical imaging delivery. Tool B (CT Cardiomegaly) provides valuable automation for a specific measurement from CT images using machine learning, but it is a more focused application of AI to existing data rather than a new modality or point-of-care system.

Support & Docs

Lung AI

Tool A (Lung AI) offers a dedicated 'Support Center' with readily available 'User Manuals,' 'Release Notes,' and multiple direct contact options including email, phone, and ticket submission. It also provides 'AI-powered POCUS education and training' (Exo U) to assist users. While Tool B's company (Innolitics) offers professional regulatory and QMS support, specific product support and documentation for CT Cardiomegaly are not explicitly detailed in the provided information in the same comprehensive manner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Lung AI	CT Cardiomegaly
Tool Name	Lung AI	CT Cardiomegaly
Company	Exo	Innolitics
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Radiology & Imaging AI
Specialties	Cardiology, Emergency Medicine, Pulmonology	Cardiology, Radiology
Primary AI Function	AI-powered detection for cardiac and lung conditions, guided image capture	Automated cardiothoracic ratio measurement from CT images
Specific AI Detections/Measurements	AI-powered detection of pleural effusion, AI-powered detection of consolidation/atelectasis, Automated AI-based indicators for cardiac conditions (e.g., heart failure, hypertrophy)	Automatic cardiothoracic ratio measurement, Segmentation of heart and thoracic cavity, Calculates linear and area-based cardiothoracic ratios

Videos

Demos, reviews, and walkthroughs featuring Lung AI and CT Cardiomegaly.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows, given one is a real-time imaging device and the other is a post-imaging analysis software?

Lung AI (Exo) integrates directly into point-of-care ultrasound (POCUS) workflows, providing real-time AI-powered insights during scans for immediate clinical decisions at the bedside. CT Cardiomegaly (Innolitics) integrates into a radiology workflow by processing existing CT chest images to provide automated cardiothoracic ratio measurements, typically as a command-line software tool that outputs PDF and JSON reports for review.

Which medical specialties would benefit most from each tool, considering their specific functionalities?

Lung AI (Exo) is designed for cardiologists, emergency physicians, and pulmonologists, offering real-time AI assistance for cardiac and lung ultrasound at the point of care, aiding in the detection of conditions like pleural effusion, consolidation/atelectasis, and cardiac pathologies. CT Cardiomegaly (Innolitics) is primarily suited for radiologists and cardiologists who interpret CT chest images and require automated, quantitative measurements for cardiomegaly detection.

What information is available regarding the accuracy and validation of the AI algorithms in each tool?

CT Cardiomegaly (Innolitics) explicitly states its machine learning algorithms for cardiothoracic ratio measurement have been validated against manual measurements performed by board-certified radiologists, with reported Dice scores of 0.95 for heart segmentation and 0.98 for inner chest segmentation. Lung AI (Exo) features AI-powered detection for conditions like pleural effusion and consolidation/atelectasis, with rigorous clinical studies showing high sensitivity and specificity in the 'excellent' range, and improved detection capabilities for clinicians across varying expertise levels.

What is the expected learning curve for physicians and the time required to integrate each tool effectively into practice?

Lung AI (Exo) emphasizes ease of use with its handheld platform and offers 'Exo U' for AI-powered POCUS education and training, suggesting a relatively quick learning curve for clinical use. CT Cardiomegaly (Innolitics), being command-line software deployed via Docker, may require initial IT setup expertise, but once configured, its automated measurement process should offer rapid value in image analysis.

Do these tools offer features for audit trails or detailed reporting that could support clinical documentation and security beyond standard compliance?

CT Cardiomegaly (Innolitics) generates PDF and JSON reports of its measurements, which can serve as documented records for clinical review and auditing purposes. Lung AI (Exo) processes AI on-device, which inherently limits data transmission, but the provided information does not explicitly detail specific audit trail features for its real-time findings.

What are the key considerations for deploying these tools across multiple clinical sites or departments?

Deploying Lung AI (Exo) across multiple sites would involve distributing and training staff on the handheld Exo Iris devices, with AI processing occurring on-device without internet connectivity. CT Cardiomegaly (Innolitics) would require IT teams to set up and manage Docker containers with the command-line software on servers at each site where CT images are processed.

To what extent can each tool integrate with existing Electronic Health Record (EHR) systems?

CT Cardiomegaly (Innolitics) generates both PDF and JSON reports, with the JSON output offering potential for automated parsing and deeper integration into EHR systems for structured data entry. Lung AI (Exo), as a real-time, on-device ultrasound platform, would likely require manual input of its findings into the EHR, though specific integration capabilities are not detailed in the provided information.